See February's 10 most-read stories, including Malaysia's dietary supplement association plans in tackling unauthorised sales on third-party e-commerce sites, China's regulations on health foods filing, Blackmores financial performance...
The timing of market entry, familiarity with regulations, and detailed consumer understanding are crucial for firms considering opportunities within Korea’s new General Foods with Function Claims policy, according to a regulatory expert in the country.
Medlab has embarked on clinical trials at varying stages for a number of its probiotics, including those targeted at alleviating depression, mucositis caused by cancer treatment, as well as addressing non-communicable diseases (NCDs).
South Korea will start the third phase of its mandatory traceability programme for special purpose foods, while international brands selling co-enzyme Q10, fish oil and melatonin into China for the first time will still need to enter the market via the...
Australia exchange ASX-listed company Jatcorp (previously known as Jatenergy) is to manufacture its probiotics-containing milk powder in-house from next month, with a launch date slated for April for its new products.
See January's 10 most read stories, including new data on how the gut microbiome is linked to severity of COVID-19, Indian firm Windlas Biotech's launch of an artemisinin supplement as an adjunctive to COVID-19 treatment and more.
Interest in the infant nutrition benefits of bifidobacteria is soaring, with a raft of papers published in the last year, and a growing understanding of the impact that human residential strains can have on early-life development.